Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Sale of 3,000 EBS shares, $19.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Emergent BioSolutions Inc. (EBS) | Sale | 3,000 | $19.6K |
| Jul 2, 2026 | Emergent BioSolutions Inc. (EBS) | Sale | 3,000 | $25.2K |
| Jun 10, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 694 | $5.6K |
| May 1, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 100,111 | n/a |
| Apr 3, 2026 | Emergent BioSolutions Inc. (EBS) | Sale | 4,000 | $33.8K |
| Mar 6, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 9,397 | $79.3K |
| Mar 3, 2026 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 116 | $945.40 |
| Feb 11, 2026 | Emergent BioSolutions Inc. (EBS) | Disposition to Issuer | 8,655 | $94.5K |
| Jun 10, 2025 | Emergent BioSolutions Inc. (EBS) | Tax Withholding | 464 | $3.1K |
| Mar 10, 2025 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 62,500 | n/a |